Carlos A. Cardenas
Melanoma is a critical issue in the field of Dermatology-Oncology, accounting for a significant portion of skin cancer deaths worldwide. In 2023, it is estimated that there will be approximately 106,110 new cases of melanoma and 9,940 deaths from melanoma in the United States alone1. These numbers highlight the urgent need for improved diagnostic and prognostic techniques that can support personalized care and treatment strategies to improve patient outcomes